Search research articles
Contact Us
Filters
Showing results (81-90 of 208) with videos related to
Page
of 21
Sort By:
Blood
|
August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Steven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study
Michelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Haematologica
|
July 18, 2024
Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from <i>TET2</i>-/<i>DNMT3A</i>-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
Natasha E Lewis, Kseniya Petrova-Drus, Rohan Sardana, et al.
American Journal of Hematology
|
March 22, 2019
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry
Robert N Stuver, Niloufer Khan, Marc Schwartz, et al.
Journal of the American Academy of Dermatology
|
February 1, 2019
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
Meenal K Kheterpal, Julia Dai, Shamir Geller, et al.
Cancer
|
June 22, 2010
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score
Adrienne A Phillips, Iuliana Shapira, Robert D Willim, et al.
Hematological Oncology
|
July 13, 2016
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
Barbara Pro, Steven M Horwitz, H Miles Prince, et al.
American Journal of Hematology
|
February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study
Jorge J Castillo, Brady E Beltran, Michele Bibas, et al.
CA: a Cancer Journal for Clinicians
|
June 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable
Jie Xiong, Yok-Lam Kwong, Laurence de Leval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
Alison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 208) with videos related to
Sort By:
Page
of 21
Blood
|
August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
Steven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study
Michelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.
Haematologica
|
July 18, 2024
Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from <i>TET2</i>-/<i>DNMT3A</i>-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
Natasha E Lewis, Kseniya Petrova-Drus, Rohan Sardana, et al.
American Journal of Hematology
|
March 22, 2019
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry
Robert N Stuver, Niloufer Khan, Marc Schwartz, et al.
Journal of the American Academy of Dermatology
|
February 1, 2019
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
Meenal K Kheterpal, Julia Dai, Shamir Geller, et al.
Cancer
|
June 22, 2010
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score
Adrienne A Phillips, Iuliana Shapira, Robert D Willim, et al.
Hematological Oncology
|
July 13, 2016
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
Barbara Pro, Steven M Horwitz, H Miles Prince, et al.
American Journal of Hematology
|
February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study
Jorge J Castillo, Brady E Beltran, Michele Bibas, et al.
CA: a Cancer Journal for Clinicians
|
June 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curable
Jie Xiong, Yok-Lam Kwong, Laurence de Leval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
Alison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.
Page
of 21